Top Markets
#1 Siren Siren +34.29%
#2 Wiki Cat Wiki Cat +29.28%
#3 Bitway Bitway +20.25%
#4 Ribbita by Virtuals Ribbita by Virtuals +19.79%
#5 TRIA TRIA +17.08%
#6 PulseChain PulseChain +16.92%
#7 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.84%
#8 Velvet Velvet +15.27%
#9 Cysic Cysic +14.22%
#10 The Grays Currency The Grays Currency +14.20%
Coin of the day
Siren Siren
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
LexaGene Holdings Inc. LexaGene Holdings Inc.

LexaGene Holdings Inc.

0V43
Clasificación en acciones #30874
LexaGene Holdings Inc. is a biotechnology firm specializing in the invention,... LexaGene Holdings Inc. is a biotechnology firm specializing in the invention, refinement, and commercialization of systems for detecting pathogens. The company's flagship product, MiQLab, is an automated pathogen identification system engineered to revolutionize diagnostics in diverse sectors, including animal and human healthcare, food and water quality assurance, and other life science applications. This advanced platform functions directly at the location of sample collection, providing remarkable simplicity, heightened sensitivity, and extensive pathogen screening capabilities. Founded in 2007, LexaGene is headquartered in Beverly, Massachusetts.
Precio por acción
$0.1174299
Última sincronización: 2023-02-22
Capitalización bursátil
$15.21M
Cambio (1 día)
-0.92%
Cambio (1 año)
0.00%
País
US
Comercio LexaGene Holdings Inc. (0V43)

Categoría

Healthcare
Ganancias de LexaGene Holdings Inc. (0V43)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di LexaGene Holdings Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de LexaGene Holdings Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE